274 related articles for article (PubMed ID: 31721892)
1. Association of BDNF, HTR2A, TPH1, SLC6A4, and COMT polymorphisms with tDCS and escitalopram efficacy: ancillary analysis of a double-blind, placebo-controlled trial.
Brunoni AR; Carracedo A; Amigo OM; Pellicer AL; Talib L; Carvalho AF; Lotufo PA; Benseñor IM; Gattaz W; Cappi C
Braz J Psychiatry; 2020 Apr; 42(2):128-135. PubMed ID: 31721892
[TBL] [Abstract][Full Text] [Related]
2. Impact of 5-HTTLPR and BDNF polymorphisms on response to sertraline versus transcranial direct current stimulation: implications for the serotonergic system.
Brunoni AR; Kemp AH; Shiozawa P; Cordeiro Q; Valiengo LC; Goulart AC; Coprerski B; Lotufo PA; Brunoni D; Perez AB; Fregni F; Benseñor IM
Eur Neuropsychopharmacol; 2013 Nov; 23(11):1530-40. PubMed ID: 23615118
[TBL] [Abstract][Full Text] [Related]
3. The Escitalopram versus Electric Current Therapy for Treating Depression Clinical Study (ELECT-TDCS): rationale and study design of a non-inferiority, triple-arm, placebo-controlled clinical trial.
Brunoni AR; Sampaio-Junior B; Moffa AH; Borrione L; Nogueira BS; Aparício LV; Veronezi B; Moreno M; Fernandes RA; Tavares D; Bueno PV; Seibt O; Bikson M; Fraguas R; Benseñor IM
Sao Paulo Med J; 2015; 133(3):252-63. PubMed ID: 26176930
[TBL] [Abstract][Full Text] [Related]
4. Plasma biomarkers in a placebo-controlled trial comparing tDCS and escitalopram efficacy in major depression.
Brunoni AR; Padberg F; Vieira ELM; Teixeira AL; Carvalho AF; Lotufo PA; Gattaz WF; Benseñor IM
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Aug; 86():211-217. PubMed ID: 29894705
[TBL] [Abstract][Full Text] [Related]
5. Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression.
Brunoni AR; Moffa AH; Sampaio-Junior B; Borrione L; Moreno ML; Fernandes RA; Veronezi BP; Nogueira BS; Aparicio LVM; Razza LB; Chamorro R; Tort LC; Fraguas R; Lotufo PA; Gattaz WF; Fregni F; Benseñor IM;
N Engl J Med; 2017 Jun; 376(26):2523-2533. PubMed ID: 28657871
[TBL] [Abstract][Full Text] [Related]
6. Antidepressant effects of tDCS are associated with prefrontal gray matter volumes at baseline: Evidence from the ELECT-TDCS trial.
Bulubas L; Padberg F; Bueno PV; Duran F; Busatto G; Amaro E; Benseñor IM; Lotufo PA; Goerigk S; Gattaz W; Keeser D; Brunoni AR
Brain Stimul; 2019; 12(5):1197-1204. PubMed ID: 31105027
[TBL] [Abstract][Full Text] [Related]
7. International randomized-controlled trial of transcranial Direct Current Stimulation in depression.
Loo CK; Husain MM; McDonald WM; Aaronson S; O'Reardon JP; Alonzo A; Weickert CS; Martin DM; McClintock SM; Mohan A; Lisanby SH;
Brain Stimul; 2018; 11(1):125-133. PubMed ID: 29111077
[TBL] [Abstract][Full Text] [Related]
8. BDNF plasma levels after antidepressant treatment with sertraline and transcranial direct current stimulation: results from a factorial, randomized, sham-controlled trial.
Brunoni AR; Machado-Vieira R; Zarate CA; Vieira EL; Vanderhasselt MA; Nitsche MA; Valiengo L; Benseñor IM; Lotufo PA; Gattaz WF; Teixeira AL
Eur Neuropsychopharmacol; 2014 Jul; 24(7):1144-51. PubMed ID: 24702987
[TBL] [Abstract][Full Text] [Related]
9. Genetic variation in the tryptophan hydroxylase 2 gene moderates depressive symptom trajectories and remission over 8 weeks of escitalopram treatment.
Su YA; Li JT; Dai WJ; Liao XM; Dong LC; Lu TL; Bousman C; Si TM
Int Clin Psychopharmacol; 2016 May; 31(3):127-33. PubMed ID: 26745768
[TBL] [Abstract][Full Text] [Related]
10. Impact of monoamine-related gene polymorphisms on hippocampal volume in treatment-resistant depression.
Phillips JL; Batten LA; Tremblay P; Aldosary F; Du L; Blier P
Acta Neuropsychiatr; 2015 Dec; 27(6):353-61. PubMed ID: 25990886
[TBL] [Abstract][Full Text] [Related]
11. Association between serotonin 2A receptor (HTR2A), serotonin transporter (SLC6A4) and brain-derived neurotrophic factor (BDNF) gene polymorphisms and citalopram/sertraline induced sexual dysfunction in MDD patients.
Oz MD; Baskak B; Uckun Z; Artun NY; Ozdemir H; Ozel TK; Ozguven HD; Suzen HS
Pharmacogenomics J; 2020 Jun; 20(3):443-450. PubMed ID: 31792367
[TBL] [Abstract][Full Text] [Related]
12. Association of serotonin transporter (SLC6A4) and receptor (5HTR1A, 5HTR2A) polymorphisms with response to treatment with escitalopram in patients with major depressive disorder: A preliminary study.
Basu A; Chadda RK; Sood M; Kaur H; Kukreti R
Indian J Med Res; 2015 Jul; 142(1):40-5. PubMed ID: 26261165
[TBL] [Abstract][Full Text] [Related]
13. Somatization in major depression--clinical features and genetic associations.
Klengel T; Heck A; Pfister H; Brückl T; Hennings JM; Menke A; Czamara D; Müller-Myhsok B; Ising M
Acta Psychiatr Scand; 2011 Oct; 124(4):317-28. PubMed ID: 21838737
[TBL] [Abstract][Full Text] [Related]
14. Genetic predictors of response to treatment with citalopram in depression secondary to traumatic brain injury.
Lanctôt KL; Rapoport MJ; Chan F; Rajaram RD; Strauss J; Sicard T; McCullagh S; Feinstein A; Kiss A; Kennedy JL; Bassett AS; Herrmann N
Brain Inj; 2010; 24(7-8):959-69. PubMed ID: 20515362
[TBL] [Abstract][Full Text] [Related]
15. Prefrontal resting-state connectivity and antidepressant response: no associations in the ELECT-TDCS trial.
Bulubas L; Padberg F; Mezger E; Suen P; Bueno PV; Duran F; Busatto G; Amaro E; Benseñor IM; Lotufo PA; Goerigk S; Gattaz W; Keeser D; Brunoni AR
Eur Arch Psychiatry Clin Neurosci; 2021 Feb; 271(1):123-134. PubMed ID: 32880057
[TBL] [Abstract][Full Text] [Related]
16. Cognitive changes after tDCS and escitalopram treatment in major depressive disorder: Results from the placebo-controlled ELECT-TDCS trial.
Moreno ML; Goerigk SA; Bertola L; Suemoto CK; Razza LB; Moffa AH; Veronezi BP; Tort L; Nogueira BS; Gattaz WF; Fraguas R; Padberg F; Lotufo PA; Benseñor IM; Brunoni AR
J Affect Disord; 2020 Feb; 263():344-352. PubMed ID: 31969264
[TBL] [Abstract][Full Text] [Related]
17. Parsing the antidepressant effects of non-invasive brain stimulation and pharmacotherapy: A symptom clustering approach on ELECT-TDCS.
Goerigk SA; Padberg F; Chekroud A; Kambeitz J; Bühner M; Brunoni AR
Brain Stimul; 2021; 14(4):906-912. PubMed ID: 34048940
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenetics in major depression: a comprehensive meta-analysis.
Niitsu T; Fabbri C; Bentini F; Serretti A
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():183-94. PubMed ID: 23733030
[TBL] [Abstract][Full Text] [Related]
19. Role of Serotonin Transporter and Receptor Gene Variations in the Acute Effects of MDMA in Healthy Subjects.
Vizeli P; Meyer Zu Schwabedissen HE; Liechti ME
ACS Chem Neurosci; 2019 Jul; 10(7):3120-3131. PubMed ID: 30589533
[TBL] [Abstract][Full Text] [Related]
20. Antidepressive-drug-induced bodyweight gain is associated with polymorphisms in genes coding for COMT and TPH1.
Secher A; Bukh J; Bock C; Koefoed P; Rasmussen HB; Werge T; Kessing LV; Mellerup E
Int Clin Psychopharmacol; 2009 Jul; 24(4):199-203. PubMed ID: 19474754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
